Raltegravir is an essential component of combination therapy used to treat HIV infection, caused by the human immunodeficiency virus that leads to acquired immune deficiency syndrome (AIDS). Typically prescribed to patients who have received previous HIV medications, Raltegravir does not provide a cure or prevent HIV/AIDS.
Its mechanism of action involves suppressing viral replication and potentially slowing down immune system deterioration. This effect can help delay the onset of AIDS-related complications and symptoms commonly associated with HIV disease. It’s important to note that Raltegravir does not prevent HIV transmission to others, so precautionary measures must still be taken.
Additionally, individuals receiving this medication may continue to experience other health issues typically related to AIDS or HIV disease. It’s crucial to obtain a doctor’s prescription to access Raltegravir, and it is available in various forms including tablets, chewable tablets, and powder for suspension.